The Association of Metastasis Pattern and Management of Metastatic Disease with Oncological Outcomes in Patients with Malignant Peripheral Nerve Sheath Tumors: A Multicenter Cohort Study.
distant metastasis
malignant peripheral nerve sheath tumor
neurofibromatosis 1
overall survival
prognostic factors
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
12 Oct 2021
12 Oct 2021
Historique:
received:
21
08
2021
revised:
30
09
2021
accepted:
08
10
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
This multicenter cohort study aimed to identify clinicopathologic and treatment-related factors associated with the development of distant metastasis (DM) and with overall survival (OS) after DM diagnosis in patients with malignant peripheral nerve sheath tumors (MPNST). All patients diagnosed with primary MPNST from 1988 to 2019 who were surgically treated for the primary tumor were included. Multivariable Cox regression analyses were performed to identify factors associated with DM and OS after DM diagnosis. A total of 383 patients were included in this analysis, of which 150 developed metastatic disease. No differences in clinicopathologic characteristics and clinical outcome were found between patients with synchronous and metachronous DM. Neurofibromatosis type 1 (NF1), high grade, tumor size, triton and R2 resections were independent risk factors for the development of DM. NF1 and more than two metastasis sites were independently associated with worse OS after DM diagnosis. Metastasectomy, chemotherapy and the metastatic site category 'other' were associated with prolonged survival after DM diagnosis. This analysis provides important insights into clinicopathologic and treatment factors associated with outcomes in metastatic MPNST. Moreover, NF1-status is associated with a higher risk of DM; it is also independently associated with worse survival in metastatic MPNST.
Identifiants
pubmed: 34680262
pii: cancers13205115
doi: 10.3390/cancers13205115
pmc: PMC8533923
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Hum Pathol. 2017 Sep;67:1-10
pubmed: 28551330
Eur J Cancer. 2020 Jan;124:77-87
pubmed: 31760312
Cancer. 2011 Jan 15;117(2):372-9
pubmed: 20830769
Cancer. 2001 May 15;91(10):1914-26
pubmed: 11346874
Eur J Cancer. 2018 May;94:187-198
pubmed: 29574364
BMC Med. 2017 Apr 10;15(1):78
pubmed: 28391775
Sarcoma. 2002;6(2):69-73
pubmed: 18521331
Ann Surg. 2009 Jun;249(6):1014-22
pubmed: 19474676
Eur J Cancer. 2010 Jan;46(1):72-83
pubmed: 19853437
Cancer. 2006 Sep 1;107(5):1065-74
pubmed: 16881077
Ann Surg Oncol. 2012 Mar;19(3):878-85
pubmed: 21861229
Cancer. 2020 Dec 1;126(23):5098-5108
pubmed: 32910462
Am J Surg Pathol. 2016 Jul;40(7):896-908
pubmed: 27158754
Ann Surg Oncol. 2013 Jan;20(1):66-72
pubmed: 22878618
Cancer. 2007 Nov 1;110(9):2050-60
pubmed: 17828771
Acta Neurochir (Wien). 2021 Feb;163(2):521-529
pubmed: 33219865
J Neurosurg. 2017 Jan;126(1):319-329
pubmed: 27035165
Cancer. 2011 Mar 1;117(5):1049-54
pubmed: 20945333
J Neurooncol. 2020 May;147(3):701-709
pubmed: 32239432
Cancer. 1985 Jun 1;55(11):2543-9
pubmed: 3922610
Am J Clin Oncol. 2019 Jan;42(1):6-11
pubmed: 30048248
J Surg Oncol. 2015 Jul;112(1):103-6
pubmed: 26179670
J Adolesc Young Adult Oncol. 2020 Dec;9(6):628-638
pubmed: 32379517
Cancer Med. 2019 Apr;8(4):1368-1378
pubmed: 30916474
Am J Clin Oncol. 2014 Jun;37(3):272-7
pubmed: 23275272
Cancer. 2003 May 15;97(10):2530-43
pubmed: 12733153
Arch Pathol Lab Med. 2006 Oct;130(10):1448-53
pubmed: 17090186
Ann Thorac Surg. 2009 Sep;88(3):877-84; discussion 884-5
pubmed: 19699915
J Thorac Cardiovasc Surg. 2017 Jul;154(1):319-330.e1
pubmed: 28395901
Ann Oncol. 2021 Nov;32(11):1348-1365
pubmed: 34303806
Clin Transl Oncol. 2016 Mar;18(3):310-6
pubmed: 26243399
Eur J Surg Oncol. 2009 Apr;35(4):356-61
pubmed: 18294807
Oncol Res Treat. 2020;43(11):613-619
pubmed: 32854101
Radiother Oncol. 2019 Aug;137:61-70
pubmed: 31078939
Arch Neurol. 1988 May;45(5):575-8
pubmed: 3128965
Eur J Cancer. 2020 Dec;141:128-136
pubmed: 33137588